डॉ. अग्रवाल हेल्थ केअर शेअर किंमत

Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, 2025, at the analyst meet held on August 04, 2026, is available on the website of the Company.

• बीएसई इंडिया
• 2 दिवस 18 तासांपूर्वी

<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Dr. Agarwals Health Care announced Q1FY27 results</strong></span></h3><p><strong _ngcontent-ng-c3377174747="">एकत्रित फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue from Operations:</strong> The company reported revenue of Rs 614.02 crore in Q1FY27, a growth of 26.0% compared to Rs 487.42 crore in Q1FY26. On a QoQ basis, revenue grew by 8.85% from Rs 564.11 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Income:</strong> Total income for Q1FY27 stood at Rs 620.43 crore, reflecting a YoY growth of 23.9% from Rs 500.81 crore in Q1FY26 and a QoQ increase of 7.58% from Rs 576.69 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">EBITDA:</strong> EBITDA grew by 25.2% YoY to Rs 176.82 crore in Q1FY27 from Rs 141.25 crore in Q1FY26. QoQ EBITDA increased by 1.59% from Rs 174.05 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">EBITDA मार्जिन:</strong> Q1FY26 मध्ये 28.2% च्या तुलनेत Q1FY27 साठी EBITDA मार्जिन 28.5% होते.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Profit After Tax (PAT):</strong> PAT for Q1FY27 stood at Rs 55.02 crore, an increase of 44.6% YoY from Rs 38.06 crore in Q1FY26. On a QoQ basis, PAT grew by 10.13% from Rs 49.96 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">PAT Margin:</strong> The PAT margin for the quarter was 8.9% compared to 7.6% in Q1FY26.</li></ul><p><strong _ngcontent-ng-c3377174747="">स्टँडअलोन फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue from Operations:</strong> Standalone revenue was Rs 382.62 crore in Q1FY27, up 26.8% YoY from Rs 301.72 crore in Q1FY26 and up 9.99% QoQ from Rs 347.86 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Income:</strong> Standalone total income stood at Rs 386.04 crore in Q1FY27, a growth of 22.65% YoY from Rs 314.75 crore in Q1FY26 and 9.03% QoQ from Rs 354.07 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">EBITDA:</strong> Standalone EBITDA was Rs 98.99 crore in Q1FY27, a growth of 24.0% YoY from Rs 79.83 crore in Q1FY26 and 0.93% QoQ from Rs 98.08 crore in Q4FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Profit After Tax (PAT):</strong> Standalone PAT for Q1FY27 was Rs 16.67 crore, representing a 64.89% YoY growth from Rs 10.11 crore in Q1FY26 and a 57.26% QoQ increase from Rs 10.60 crore in Q4FY26.</li></ul><p><strong _ngcontent-ng-c3377174747="">बिझनेस हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Network Expansion:</strong> As of June 30, 2026, the company's network reached 304 facilities. During the quarter, 18 new facilities were added, consisting of 1 Tertiary, 15 Secondary, and 2 Primary facilities.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Surgical Performance:</strong> The company performed 91,082 surgeries in Q1FY27, marking a growth of 15.5% YoY.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Greenfield Projects:</strong> The company commissioned 16 new surgical facilities in Q1FY27, which is the highest ever in a single quarter for the firm.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">विभागनिहाय कामगिरी (एकत्रित):</strong><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">India Operations:</strong> Revenue from India stood at Rs 552 crore, a growth of 25.3% YoY.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Mature Facilities:</strong> Revenue from mature facilities was Rs 485 crore, growing at 37.1% YoY.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue Mix:</strong> Sale of Services contributed 77.7%, and Sale of Products contributed 22.3% to revenue from operations.</li></ul></li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">कॉर्पोरेट विकास:</strong><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Nigeria Expansion:</strong> The company proposed the incorporation of a wholly-owned subsidiary in Nigeria, 'Orbit Health Care Services (Nigeria) Ltd', to engage in comprehensive eye care services.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Audit Appointments:</strong> M/s. S.R. Batliboi & Associates LLP were appointed as Statutory Auditors until the conclusion of the 20th AGM. M/s. KPMG Assurance and Consulting Services LLP were appointed as Internal Auditors for the financial year 2026-27.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">IPO Proceeds:</strong> Out of the fresh issue proceeds of Rs 300 crore, the company has utilized Rs 282.31 crore up to June 30, 2026. The unutilized amount of Rs 17.69 crore is intended for general corporate purposes.</li></ul></li></ul><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Adil Agarwal, CEO, Dr. Agarwal’s Health Care</strong><strong>, said:</strong> “This has been an exceptional quarter for us on multiple fronts. We delivered our highest ever sequential quarter-on-quarter revenue growth, underscoring the strong momentum across our business. We also set a new record with the launch of 16 greenfield surgical facilities in a single quarter — the highest ever in our history. Revenue from operations for the quarter stood at Rs 614 crore, a growth of 26.0% over the same period last year, driven by healthy growth across all of our regions. Our EBITDA rose by 25.2% to Rs 177 crore, underscoring our focus on operational efficiency and cost discipline despite rising greenfield losses driven by 23 surgical facilities launched in the last six months. Profit after tax rose to Rs 55 crore, up 44.6% year-on-year.</p><p _ngcontent-ng-c3377174747="">Operationally, our network grew to 304 eye care facilities as of June 30, 2026, with 18 new additions during the quarter. We served over 8.8 lakh+ patients and performed c.91,000+ surgeries, supported by our team of 1,050+ doctors. Q1FY27 witnessed a record addition of 16 surgical facilities, delivering nearly half of FY26's total surgical facility additions in a single quarter. Our greenfield execution engine is firing, and with a strong pipeline already in place, we remain confident of delivering on the full-year plan.”</p><p><a class="lb" href="/marathi/get-document/post/pdf/5763516/" target="_blank">रिझल्ट PDF</a></p>

• ट्रेंडलाईन
• 2 दिवस 22 तासांपूर्वी

Dr. Agarwal''s Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.

• बीएसई इंडिया
• 2 दिवस 23 तासांपूर्वी